Targeted mRNA delivery provides a transformative approach for managing chronic inflammatory conditions. Activated proinflammatory macrophages drive these diseases and overexpress the CD44 receptor. Consequently, researchers are utilizing hyaluronic acid (HA), the natural ligand of CD44, to guide lipid nanoparticles (LNPs) to these specific cells. However, the effectiveness of this targeting depends heavily on the surface chemistry of the nanoparticle. A recent study investigated how poly(ethylene glycol) (PEG) concentration affects delivery efficiency.

Advancements in Targeted mRNA Delivery

Scientists compared HA-functionalized LNPs containing either 1.5% or 0.5% PEG. Interestingly, the 0.5% PEG formulation showed significantly higher uptake in activated macrophages. In contrast, the 1.5% PEG version performed poorly, suggesting that high PEG density blocks the interaction between HA and the CD44 receptor. Furthermore, microfluidic mixing techniques ensured the production of high-quality, uniform particles for testing. This precise engineering allows for better selectivity while maintaining high transfection efficiency.

Clinical Relevance and Future Scope

Selective therapy could revolutionize the treatment of atherosclerosis, rheumatoid arthritis, and metabolic disorders. By delivering mRNA that encodes anti-inflammatory proteins, clinicians can modulate the immune response directly at the site of inflammation. Moreover, this strategy minimizes off-target effects on healthy tissues. Therefore, optimizing ligand-functionalized LNPs remains a critical goal for pharmaceutical development.

Frequently Asked Questions

How does hyaluronic acid improve mRNA delivery to macrophages?

Hyaluronic acid (HA) is the natural ligand for the CD44 receptor, which is overexpressed on activated macrophages. By coating lipid nanoparticles with HA, the delivery system can specifically bind to and enter these diseased cells while sparing healthy ones.

Why is the amount of PEG important in nanoparticle design?

PEG provides stability and long circulation times for nanoparticles. However, excessive PEG can create a steric barrier that prevents targeting ligands, like HA, from binding to their intended receptors. This study found that a lower PEG concentration of 0.5% was necessary for effective macrophage targeting.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.

References

Cao M et al. Selective mRNA Delivery to Activated Macrophages via Hyaluronic Acid-Functionalized Lipid Nanoparticles with Optimized PEGylation. Biomacromolecules. 2026 Feb 10. doi: 10.1021/acs.biomac.5c02390. PMID: 41666458.

Hou X, et al. Lipid nanoparticles for mRNA delivery. Nature Reviews Materials. 2021;6(12):1078-1094.

Moradi S, et al. CD44-Targeted Lipid-Based Nanocarriers for Cancer and Inflammation. Pharmaceutics. 2022;14(10):2155.